PulseSight begins phase 1 safety study of gene therapy for geographic atrophy
Category: News
CSL Behring marks new era in treatment with milestone reimbursement model
Pneumagen’s intranasal antiviral demonstrates reduced infection
Data shows mRNA-1010 could better protect adults aged 50 and above
Positive trial results offer hope for those with ultra-rare epileptic disorder
New data show strong efficacy of CD388 in phase 2b trial
Introduction This year’s NHS ConfedExpo took place on 11–12 June at Manchester Central, bringing together around 9000 attendees. […]
PMGroup Worldwide and Visions4Health have launched the Excellence in Healthcare Partnerships (EHP) Awards to recognise collaborations that deliver […]
Enter this year’s famous competition